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A pharmacological approach to ameliorate Alzheimer's disease (AD) has not yet been established. In the
present study, we investigated the pharmacological characteristics of the recently identiﬁed memory-
enhancing compound, ISRIB for the amelioration of AD. ISRIB potently attenuated amyloid b-induced
neuronal cell death at concentrations of 12.5e25 nM, but did not inhibit amyloid b production in the
HEK293T cell line expressing the amyloid precursor protein (APP). These results suggest that ISRIB
possesses the unique pharmacological property of attenuating amyloid b-induced neuronal cell death
without affecting amyloid b production.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Alzheimer's disease (AD) is a neurodegenerative disease that is
accompanied by cognitive decline and memory loss with age. The
accumulation of b amyloid has been reported in the senile plaques
of AD brains and the b amyloid hypothesis has been proposed for
the pathogenesis of AD (1). b amyloid is produced through amyloid
precursor protein (APP) processing, which is mediated by b and g
secretases. Therefore, pharmacological strategies targeting these
secretases have been extensively studied in an attempt to amelio-
rate AD. However, these approaches have not yet succeeded and,
thus, novel strategies are still required.
Emerging evidence has indicated the possible involvement of
endoplasmic reticulum (ER) stress in the pathophysiology of AD (2,
3). The ER is an organelle involved in protein folding. Various
stressors that perturb ER function increase the accumulation oftherapy, Graduate School of
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d/4.0/).unfolded proteins and cause ER stress (4). Cells activate three major
branches of unfolded protein responses (UPR) when exposed to ER
stress, i.e.: inositol-requiring enzyme 1 (IRE1), activating tran-
scription factor 6 (ATF6), and double-stranded RNA-activated pro-
tein kinase (PKR)-like ER kinase (PERK) branches of UPR (5).
Increasing evidence suggests that pharmacological modulators of
ER stress represent an attractive strategy for the treatment of AD (2,
3). The PERK-eukaryotic translation initiation factor a (eIF2a)
branch of UPR was previously reported to be activated in the AD
brain (6), and the attenuation of the PERK branch was found to
alleviate plasticity and memory deﬁcits in AD (7). A modulator of
the integrative stress response (ISR), named ISRIB has recently been
identiﬁed (8), and reverses the effects of eIF2a phosphorylation by
regulating eIF2B (9, 10). However, it currently remains unknown
whether ISRIB ameliorates neuronal cell death in AD.2. Materials and methods
2.1. Materials
The human amyloid b1e42 and amyloid b25e35 peptides were
obtained fromWako Pure Chemical Ltd. (Japan). ISRIB was obtained
from Cayman Chemical (Ann Arbor, MI). Neurobasal medium and
B-27 supplement were obtained from Life Technologies (Waltham,
MA).nese Pharmacological Society. This is an open access article under the CC BY-NC-ND
Fig. 1. ISRIB protected against amyloid b-induced neuronal cell death. PC12 neuronal
cells were treated with the amyloid b1e42 peptide (Ab) and ISRIB and cell viability were
analyzed by measuring LDH. ISRIB dose-dependently (12.5e25 nM) attenuated
neuronal cell death. n ¼ 4e7, *p < 0.05, **p < 0.01 Dunnett's test.
Fig. 2. ISRIB attenuated amyloid b-induced ATF4 expression. The amyloid b25e35
peptide (Ab) was dissolved in H2O and pre-incubated for 4 days at 37 C. Ab (40 mM)
was simultaneously added with ISRIB (50 nM) for 4 h and ATF4 levels were analyzed by
Western blotting. ISRIB signiﬁcantly attenuated Ab-induced ATF4 expression. n ¼ 4,
*p < 0.05 paired t-test.
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The PC12 neuronal cell line was cultured in RPMI medium
containing 10% horse serum and 5% fetal calf serum. The HEK293T
cell line was cultured in DMEM medium containing 10% fetal calf
serum, 0.29 mg/ml L-glutamine, 100 units/ml of penicillin G, and
100 mg/ml of streptomycin (Nacalai Tesque, Japan). These cells were
maintained at 37 C in 5% CO2/95% air.
2.3. Measurement of amyloid b-induced cell death
Prior to being stimulated, PC12 cells were plated on poly-D-
lysine-coated 24-well plates andmaintained in neurobasal medium
containing 2% B-27 supplement and 0.5 mM L-glutamine. After
culturing for 3 days, medium was replaced with antioxidant-free
neurobasal medium and stimulated with an amyloid b peptide.
The amyloid b1e42 peptide was dissolved in 0.02% NH4OH at
200 mM, pre-incubated on ice for 30 min, and then added to the
cultured medium. The ﬁnal concentration of NH4OH in the cultured
medium was 0.002%. We analyzed amyloid b peptide-induced cell
death using a lactate dehydrogenase (LDH) assay. LDH leakage into
the cultured medium was assessed using a cytotoxicity detection
kit (Roche Molecular Biochemical) according to the manufacturer's
protocol.
2.4. Measurement of amyloid b42 protein levels by ELISA
The pCAX FLAG APP plasmid (a gift from Drs. Dennis Selkoe and
Tracy Young-Pearse, Addgene plasmid #30154) (11) was trans-
fected into HEK293T cells using a standard calcium precipitation
protocol. The amount of the amyloid b peptide released into the
cultured medium was then measured using ELISA kit (Millipore,
Billerica, MA).
2.5. Western blotting analysis
Cells were washed with ice-cold PBS and lysed in buffer con-
taining 10 mM HEPES-NaOH (pH 7.5), 150 mM NaCl, 1 mM EGTA,
1 mM Na3VO4, 10 mM NaF, 10 mg/ml aprotinin, 10 mg/ml leupeptin,
1 mM PMSF, and 1% NP-40 for 20 min. The lysates were centrifuged
at 15,000 rpm at 4 C for 20 min, and the supernatants were
collected and boiled with Laemmli buffer for 3 min. Samples were
fractionated by SDS-PAGE, and transferred at 4 C to nitrocellulose
membranes. The membranes were incubated with anti-ATF4 (Cell
signaling, Danvers, MA), anti-APP (eBioscience, San Diego, CA), and
anti-GAPDH (Acris, Germany) antibodies followed by an anti-
horseradish peroxidase-linked antibody. Peroxidase was detected
by chemiluminescence using an ECL system.
2.6. Statistical analysis
Results are expressed as the means ± S.E. Statistical analyses
were performed using Dunnett's test or a paired t-test.
3. Results
3.1. ISRIB protected amyloid b-induced neuronal cell death
Amyloid b peptides accumulate in AD brains and cause neuronal
cell death (12, 13). In order to determine whether ISRIB exerts
neuroprotective effects on AD neurons, we treated PC12 neuronal
cells with ISRIB and analyzed amyloid b1e42-induced cell death.
PC12 neuronal cells were treated with ISRIB and the amyloid b1e42
peptide for 48 h and cell death was then analyzed. As shown in
Fig. 1A, a two-fold increase was observed in cell death by theamyloid b1e42 peptide treatment and amyloid b1e42 peptide-
induced cell death was signiﬁcantly attenuated by ISRIB. The
effective dosage of ISRIB was in the order of nM (12.5e25 nM)
(Fig. 1). ISRIB has been shown to reverse the effects of eIF2a
phosphorylation by regulating eIF2B (9, 10), and inhibits the eIF2a-
induced expression of activating transcription factor 4 (ATF4) (8).
Fig. 3. ISRIB did not affect amyloid b production. (A) Amyloid b (Ab) levels were analyzed in the cultured medium 40 h after transfection of the APP plasmid. The treatment with
ISRIB (50 nM) did not affect the release of Ab. (B) Cellular APP levels in HEK293T cells were measured 40 h after transfection of the APP plasmid. APP expression levels were not
changed by the ISRIB (50 nM) treatment.
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b25e35 peptide on the expression of ATF4 in PC12 neuronal cells. We
found that the amyloid b25e35 peptide induced the expression of
ATF4 and the peptide-induced expression of ATF4 was signiﬁcantly
inhibited by ISRIB (Fig. 2).
3.2. ISRIB did not affect amyloid b production
In order to establish whether ISRIB affects amyloid b production,
we measured amyloid b levels in the cultured medium of HEK293T
cells, which overexpressed the APP gene. HEK293 cells were re-
ported to express functional secretases involved in APP processing
(14, 15). ISRIB was added 16 h after the APP plasmid had been
transfected. Forty hours after the transfection, amyloid b levels in
the cultured medium were analyzed by ELISA. Amyloid b levels
increased after the transfection (Fig. 3A). However, ISRIB did not
inhibit amyloid b secretion (Fig. 3A). We conﬁrmed that APP levels
in HEK293T cells were similar between control- and ISRIB-treated
cells (Fig. 3B). Therefore, ISRIB did not appear to affect amyloid b
production.
4. Discussion
Although ISRIB has been shown to enhance memory (8), it
currently remains unknown whether ISRIB effectively ameliorates
AD neuronal cell death. In the present study, we demonstrated that
ISRIB attenuated amyloid b-induced neuronal cell death. The
pharmacological mechanisms of action of ISRIB that attenuate
amyloid b-induced neuronal cell death have not yet been eluci-
dated. ATF4 has been identiﬁed as a transmitter of neurodegener-
ative signals in AD (13). Furthermore, it has been shown to induce
genes such as the C/EBP homologous protein (CHOP) or tribbles 3
(TRB3) (16, 17), which is involved in the induction of apoptosis. We
found ISRIB inhibit amyloid b-induced ATF4 induction. Thus, the
neuroprotective effects of ISRIB may be mediated through theinhibited induction of ATF4. It would be interesting future subject
to analyze precise role of ATF4 on neuroprotective action of ISRIB.
The dosage of ISRIB used to protect neuronal cell death was low
i.e.; in the order of nM. Furthermore, ISRIB is known to readily cross
the blood-brain barrier (8). Therefore, these results provide novel
approaches for the effective treatment of AD. The pathophysio-
logical properties of AD are accompanied by cognitive decline and
memory loss. Overall, the combined unique effects of ISRIB, namely,
enhancements in memory and neuroprotection, may represent an
attractive therapy for AD.
Conﬂict of interest
The authors have declared that no competing interests exist.
Acknowledgments
The present study was supported by a Grant-in-Aid for Scientiﬁc
Research from the Ministry of Education, Science, Sports and Cul-
ture, Japan and the Takeda Science Foundation.
References
(1) Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis.
Science. 1992;256:184e185.
(2) Hosoi T, Nomura J, Ozawa K, Nishi A, Nomura Y. Possible involvement of
endoplasmic reticulum stress in the pathogenesis of Alzheimer's disease.
Endoplasm Reticul Stress Dis. 2015;2:107e118.
(3) Hosoi T, Ozawa K. Molecular approaches to the treatment, prophylaxis, and
diagnosis of Alzheimer's disease: endoplasmic reticulum stress and immu-
nological stress in pathogenesis of Alzheimer's disease. J Pharmacol Sci.
2012;118:319e324.
(4) Hosoi T, Ozawa K. Endoplasmic reticulum stress in disease: mechanisms and
therapeutic opportunities. Clin Sci (Lond). 2010;118:19e29.
(5) Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded
protein response. Nat Rev Mol Cell Biol. 2007;8:519e529.
(6) Chang RC, Wong AK, Ng HK, Hugon J. Phosphorylation of eukaryotic initiation
factor-2a (eIF2a) is associated with neuronal degeneration in Alzheimer's
disease. Neuroreport. 2002;13:2429e2432.
T. Hosoi et al. / Journal of Pharmacological Sciences 131 (2016) 292e295 295(7) Ma T, Trinh MA, Wexler AJ, Bourbon C, Gatti E, Pierre P, et al. Suppression of
eIF2a kinases alleviates Alzheimer's disease-related plasticity and memory
deﬁcits. Nat Neurosci. 2013;16:1299e1305.
(8) Sidrauski C, Acosta-Alvear D, Khoutorsky A, Vedantham P, Hearn BR, Li H, et al.
Pharmacological brake-release of mRNA translation enhances cognitive
memory. Elife. 2013;2:e00498.
(9) Sekine Y, Zyryanova A, Crespillo-Casado A, Fischer PM, Harding HP, Ron D.
Stress responses. Mutations in a translation initiation factor identify the target
of a memory-enhancing compound. Science. 2015;348:1027e1030.
(10) Sidrauski C, Tsai JC, Kampmann M, Hearn BR, Vedantham P, Jaishankar P, et al.
Pharmacological dimerization and activation of the exchange factor eIF2B
antagonizes the integrated stress response. Elife. 2015;4:e07314.
(11) Young-Pearse TL, Bai J, Chang R, Zheng JB, LoTurco JJ, Selkoe DJ. A critical
function for b-amyloid precursor protein in neuronal migration revealed by in
utero RNA interference. J Neurosci. 2007;27:14459e14469.
(12) LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G. The Alzheimer's A
b peptide induces neurodegeneration and apoptotic cell death in transgenic
mice. Nat Genet. 1995;9:21e30.(13) Baleriola J, Walker CA, Jean YY, Crary JF, Troy CM, Nagy PL, et al. Axonally
synthesized ATF4 transmits a neurodegenerative signal across brain regions.
Cell. 2014;158:1159e1172.
(14) Zhang L, Song L, Terracina G, Liu Y, Pramanik B, Parker E. Biochemical char-
acterization of the gamma-secretase activity that produces b-amyloid pep-
tides. Biochemistry. 2001;40:5049e5055.
(15) Peters I, Igbavboa U, Schütt T, Haidari S, Hartig U, Rosello X, et al. The inter-
action of b-amyloid protein with cellular membranes stimulates its own
production. Biochim Biophys Acta. 2009;1788:964e972.
(16) Harding HP, Novoa I, Zhang Y, Zeng H, Wek R, Schapira M, et al. Regulated
translation initiation controls stress-induced gene expression in mammalian
cells. Mol Cell. 2000;6:1099e1108.
(17) Ohoka N, Yoshii S, Hattori T, Onozaki K, Hayashi H. TRB3, a novel ER stress-
inducible gene, is induced via ATF4-CHOP pathway and is involved in cell
death. EMBO J. 2005;24:1243e1255.
